Institution
Wilkes University
Education•Wilkes-Barre, Pennsylvania, United States•
About: Wilkes University is a education organization based out in Wilkes-Barre, Pennsylvania, United States. It is known for research contribution in the topics: Population & Pharmacy. The organization has 616 authors who have published 1032 publications receiving 21050 citations. The organization is also known as: Wilkes & Wilkes College.
Topics: Population, Pharmacy, Seed dispersal, Curriculum, Electron mobility
Papers published on a yearly basis
Papers
More filters
TL;DR: A compactly supported positive measure σ in the complex plane C is said to be nonminimal if there is a compactly supportable positive measure μ, not equal to σ, with logarithmic potential equal to or less than or equal to ε on C, and if σ is a non-minimal measure then there is an open set, Ω, such that every sequence of polynomials converging in L 2 ( σ ) converges normally on Ω as discussed by the authors.
1 citations
Proceedings Article•
01 Jan 19971 citations
TL;DR: In this paper, a rabbit was passively sensitized with homologous antiserum to and challenged with horse serum according to a procedure favoring the production of acute lesions of vasculitis of the pulmonary arteries, arterioles, and veins.
1 citations
01 Jan 1995
1 citations
TL;DR: BIS is effective in reducing symptoms and improving lung function in children with asthma and should be used in children ages 1–8 years with moderate to severe persistent asthma who are unable to effectively use a metered-dose inhaler with or without a spacer or a dry-powder inhaler.
Abstract: OBJECTIVE:To evaluate the role of budesonide inhalation suspension (BIS) in the treatment of children with asthma.DATA SOURCES:Literature identified through Medline (1966–November 2000) and references obtained from selected articles. Search terms included budesonide and asthma.DATA SYNTHESIS:Asthma is a chronic inflammatory disease that affects approximately 4.8 million children in the US. By reducing inflammation, corticosteroids decrease symptoms and improve lung function. As the first nebulized corticosteroid, BIS offers an important treatment option for children with persistent asthma.CONCLUSIONS:BIS is effective in reducing symptoms and improving lung function in children with asthma. It should be used in children ages 1–8 years with moderate to severe persistent asthma who are unable to effectively use a metered-dose inhaler with or without a spacer or a dry-powder inhaler.
1 citations
Authors
Showing all 619 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| William I. Rose | 71 | 241 | 13418 |
| Hsueh-Chia Chang | 62 | 327 | 12670 |
| Douglas A. Burns | 45 | 139 | 7272 |
| James Adams | 37 | 81 | 4653 |
| Ann Kolanowski | 36 | 178 | 4333 |
| Mihir Sen | 36 | 192 | 4245 |
| Alexander Shekhtman | 35 | 120 | 3874 |
| Ned Fetcher | 31 | 64 | 4011 |
| Michael P. Kaschak | 30 | 73 | 5125 |
| William Terzaghi | 30 | 70 | 4547 |
| Thomas M. Walski | 30 | 136 | 4219 |
| Samuel Merrill | 29 | 75 | 2621 |
| Michael A. Steele | 27 | 74 | 2863 |
| Gregory S. Harms | 27 | 47 | 3268 |
| Michael R. Gionfriddo | 26 | 87 | 3074 |